ArticleCurrent developments in nutrition2024
Monitoring Biofortification Program Performance and Potential for Impact: Indicators, Methods, and Learnings from the Commercialization of Biofortified Crops Program in Six Countries across Africa and Asia.
Article in Current developments in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Estimating the Number of People Eating Biofortified Foods On-Farm and from Markets: a Detailed Methodology and Tool.Current developments in nutrition · 2026Article
- Dietary approaches to support cognition in older adults: a systematic review.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Biofortification of staple crops is a food-based strategy to reduce the high global burden of micronutrient deficiencies. Monitoring program performance is essential to ensure biofortification programs have high potential for impact; however, few indicators and methods for doing so are publicly available. Objective: We documented the set of standardized indicators and methods used to monitor the Commercialization of Biofortified Crops (CBC) program and reviewed their strengths and limitations. Methods: Following the CBC program impact pathway, we identified and defined a set of indicators and corresponding methods. Country-level implementation teams contextualized and operationalized them to monitor 9 country-crop programs (i.e., high iron beans in Kenya and Tanzania, iron pearl millet in India, vitamin A maize in Nigeria and Tanzania, vitamin A cassava in Nigeria, zinc wheat in Pakistan and India, and zinc rice in Bangladesh) from 2020 to 2022. Results: Twenty indicators were defined across domains of seed supply, production, availability, awareness, capacity development, advocacy, and consumption of biofortified foods. Data collection methods included external and internal document review, farmer household surveys, rapid market assessments, and modeling. The strengths of these methods were that they were rapid to conduct, low cost, and simple to use. For some methods, the limitations were the potentially reduced accuracy of some results due to the use of external data sources or secondary data inputs and unavailability of data. Conclusions: The indicators and methods used in the CBC program are practical and cost effective for monitoring the implementation of biofortification programs because they generate the range of information necessary to understand how effectively a program is delivered and bolster plausibility arguments for attributing observed impacts to program activities. Further testing is needed to confirm their generalizability when applied to different contexts and paired with impact evaluations with the aim of producing publicly available global guidance documents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.